Moderna has launched a rare public attack on the US Food and Drug Administration, warning that an “unpredictable” regulator could weaken America’s lead in drug innovation. During the call, company leaders specifically argued that the FDA’s unpredictable decision-making undermines industry momentum. The comments came during the company’s Friday analyst call. This was just days after the FDA declined to accept…